Anthony Possemato

5.8k citations
14 papers · 2.4k indexed · 1 hit paper · h-index 8

Impact in

    • Ubiquitin and proteasome pathways
    • Protein Degradation and Inhibitors
    • Glycosylation and Glycoproteins Research
  • Oncology top 5%
    • Peptidase Inhibition and Analysis
    • Cancer-related Molecular Pathways

Papers in

    • Cytokine Signaling Pathways and Interactions 2
    • Advanced Proteomics Techniques and Applications 3
    • Mass Spectrometry Techniques and Applications 2

Anthony Possemato

12 papers receiving 2.4k citations

Hit Papers

Systematic and Quantitative Assessment of the Ubiquitin-Modified Proteome 2011 · 1.3k citations
1.3k20112026201620214008001.2k

Peers

Anthony Possemato
Comparison fields: 5 of 94
  • Molecular Biology 1.9k
  • Oncology 651
  • Cell Biology 362
  • Spectroscopy 280
  • Cancer Research 235
Replace Andrew Pierce with:
Andrew Pierce United Kingdom
Troels Zakarias Kristiansen United States
Kimberly A. Lee United States
Rajat Gupta Denmark
Nicole L. Solimini United States
Carol Waghorne Canada
Leanne de Koning France
Bibek Gooptu United Kingdom
Paweł K. Mazur United States
Rachel A. Craven United Kingdom
Anthony Possemato relative to Andrew Pierce United Kingdom Andrew Pierce's profile →
Citations per field
00.5×1.5×2.1×
Andrew Pierce · 1×
Citations per year

Countries citing papers authored by Anthony Possemato

Since Specialization
Citations

This map shows the geographic impact of Anthony Possemato's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Anthony Possemato with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Anthony Possemato more than expected).

Fields of papers citing papers by Anthony Possemato

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Anthony Possemato. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Anthony Possemato. The network helps show where Anthony Possemato may publish in the future.

Co-authorship network

The 25 scholars most cited alongside Anthony Possemato, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.

Border = papers with Anthony Possemato Line = papers co-authored together Anthony Possemato links everyone, so they are left out of the graph.

All Works

14 of 14 papers shown
#Work
1 20240
2 20244
3 20237
4 20213
5 201745
6 20160
7 201389
8 20131
9 201232
10
Systematic and Quantitative Assessment of the Ubiquitin-Modified Proteome
Hit paper breakdown →
20111287
11 2010247
12 200963
13 2008424
14 2007173

About Anthony Possemato

Anthony Possemato is a scholar working on Oncology, Spectroscopy, Molecular Biology, Cancer Research and Immunology, having authored 14 papers that have together received 2.4k indexed citations. Recurring topics across this work include Ubiquitin and proteasome pathways (4 papers), Advanced Proteomics Techniques and Applications (3 papers), Protein Tyrosine Phosphatases (2 papers), Protein Degradation and Inhibitors (2 papers), PI3K/AKT/mTOR signaling in cancer (2 papers), Mass Spectrometry Techniques and Applications (2 papers), Cytokine Signaling Pathways and Interactions (2 papers) and Galectins and Cancer Biology (2 papers). The work is most often cited by research in Molecular Biology (1.9k citations), Oncology (651 citations), Cell Biology (362 citations), Spectroscopy (280 citations) and Cancer Research (235 citations). Anthony Possemato has collaborated with scholars based in United States, Germany and Canada. Frequent co-authors include Ailan Guo, Steven P. Gygi, A. John Rush, Michael J. Comb, Jing Li, J. Wade Harper, Ramin Rad, Mathew E. Sowa, Eric J. Bennett and Edward L. Huttlin. Their work appears in journals such as Molecular Cell, Proceedings of the National Academy of Sciences, iScience, Clinical Cancer Research and Molecular Cancer Therapeutics.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026